Tivozanib Has Efficacy in Advanced Renal Cell Carcinoma Post-ICI Therapy
No benefit seen for rechallenge with nivolumab after progression in the post-immune checkpoint inhibitor setting
Adjuvant Pembrolizumab Improves Survival in Muscle-Invasive Urothelial Cancer
Improved disease-free survival seen among patients with high-risk muscle-invasive urothelial carcinoma after radical surgery
Higher Incarceration Rates Linked to Increased Cancer Mortality Rates
Increase in county- and state-level cancer mortality rates seen with higher county and state incarceration rates
Pembrolizumab + Chemo Beneficial for Early-Stage Triple-Negative Breast Cancer
Overall survival higher in group receiving pembrolizumab plus chemo versus chemotherapy alone
DBT Increases Cancer Detection Versus Digital Mammography
Lower proportion of advanced cancer seen with digital breast tomosynthesis than with DM
Excess Body Weight Linked to Increased Risk for Second Primary Neoplasm
Risk for any second primary cancer increased among those with overweight and obesity compared with those with normal weight
Adjuvant Durvalumab Extends Survival in Small Cell Lung Cancer
Significantly longer overall and progression-free survival seen among patients with limited-stage small cell lung cancer
Long-Term Survival Benefit Seen for Nivolumab in Advanced Melanoma
Continued survival benefit seen for nivolumab plus ipilimumab and for nivolumab monotherapy versus ipilimumab monotherapy
Neoadjuvant Chemo Boosts Structure Preservation Rates in Nasal, Sinus Cancer
Improvement seen in overall structure preservation rate, orbit preservation rate, and skull base preservation rate
